Promoter group acquires 14 lakh shares via warrant conversion at Ind-Swift Labs
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Essix Biosciences, part of Ind-Swift Labs promoter group, converted 14,00,000 fully convertible warrants into equity shares on October 8, 2026. This raised promoter group holding from 42.93% to 43.84% of paid-up capital, and 47.18% on diluted basis. The shares were allotted through a preferential warrant conversion, not open market purchase. Total promoter group holding now stands at 4,43,34,278 shares.
Promoter holding edges toward the 50% takeover threshold (now 43.84%, 47.18% diluted). No open offer trigger yet. Signals continued promoter commitment.